Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
British Journal of Cancer
|
July 9, 2004
Targeting the epidermal growth factor receptor
B F El-Rayes, P M LoRusso
Expert Opinion on Pharmacotherapy
|
February 5, 2002
Pancreatic cancer: the evolving role of systemic therapy
N V Adsay, B F El-Rayes, P A Philip
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
February 26, 2003
Comparison of DNA content parameters in paired, fresh tissue pretreatment biopsies and surgical resections from squamous cell carcinoma of the head and neck
B F El-Rayes, Z Maciorowski, H Pietraszkiewicz, et al.
Cancer Investigation
|
March 20, 2003
Developments in the systemic therapy of pancreatic cancer
B F el-Rayes, A F Shields, V Vaitkevicius, et al.
Current Oncology (Toronto, Ont.)
|
December 31, 2015
Analysis of liver-directed therapies in U.S. cancer patients
O B Alese, S Kim, Z Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
A phase II study of carboplatin and paclitaxel in esophageal cancer
B F El-Rayes, A Shields, M Zalupski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 11, 2012
mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)
H J Prajapati, J R Spivey, S I Hanish, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2003
Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer
B F El-Rayes, M M Zalupski, A F Shields, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 25, 2010
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers
B F El-Rayes, M Zalupski, T Bekai-Saab, et al.
British Journal of Cancer
|
October 4, 2017
A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours
K P Papadopoulos, B F El-Rayes, A W Tolcher, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
British Journal of Cancer
|
July 9, 2004
Targeting the epidermal growth factor receptor
B F El-Rayes, P M LoRusso
Expert Opinion on Pharmacotherapy
|
February 5, 2002
Pancreatic cancer: the evolving role of systemic therapy
N V Adsay, B F El-Rayes, P A Philip
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
February 26, 2003
Comparison of DNA content parameters in paired, fresh tissue pretreatment biopsies and surgical resections from squamous cell carcinoma of the head and neck
B F El-Rayes, Z Maciorowski, H Pietraszkiewicz, et al.
Cancer Investigation
|
March 20, 2003
Developments in the systemic therapy of pancreatic cancer
B F el-Rayes, A F Shields, V Vaitkevicius, et al.
Current Oncology (Toronto, Ont.)
|
December 31, 2015
Analysis of liver-directed therapies in U.S. cancer patients
O B Alese, S Kim, Z Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
A phase II study of carboplatin and paclitaxel in esophageal cancer
B F El-Rayes, A Shields, M Zalupski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 11, 2012
mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)
H J Prajapati, J R Spivey, S I Hanish, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2003
Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer
B F El-Rayes, M M Zalupski, A F Shields, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 25, 2010
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers
B F El-Rayes, M Zalupski, T Bekai-Saab, et al.
British Journal of Cancer
|
October 4, 2017
A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours
K P Papadopoulos, B F El-Rayes, A W Tolcher, et al.
Page
of 2